alara glp-1 Health update! I’ve been getting so many questions about my journey over the years, so I wanted to share what’s been working for me. 🤍 I’ve been using @allarahealth , a virtual women’s GLP-1/GIP - Elara MD

BioWorld - Saturday, July 18, 2026 Breaking News: Best of BioWorld Science: Q2See today's BioWorld Science Home Innovent gets IND for oral GLP-1 agonist To read the full story, subscribe or sign in

Both semaglutide and tirzepatide reduce insulin resistance and improve insulin sensitivity, critical for patients managing excess weight, blood sugar, and metabolic-associated liver disease

TRT Nations approach to medical weight loss includes practical guidance to help you build sustainable habits alongside your treatment

The FDA was explicit: affordability is not clinical need

Tirzepatide is technically a dual agonist GLP-1/GIP (glucose-dependent insulinotropic polypeptide) Liraglutide (Saxenda and Victoza) Each of these works in a similar way, but differs in terms of how long they stay active in the body and how they interact with different receptors